146 related articles for article (PubMed ID: 8456759)
21. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia.
Cutler N; Sramek J; Veroff A; Block G; Stauffer L; Lines C
Br J Clin Pharmacol; 1995 Mar; 39(3):333-6. PubMed ID: 7619678
[TBL] [Abstract][Full Text] [Related]
22. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Franklin FA; Nash DT; Hurley DP; Dujovne CA; Pool JL; Schnaper H; Hesney M
Am J Med; 1991 Jul; 91(1B):18S-24S. PubMed ID: 1867232
[TBL] [Abstract][Full Text] [Related]
23. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Dujovne C; Franklin FA; Hesney M; Higgins J; Langendörfer A; Pool JL; Schnaper H
Am J Cardiol; 1990 Sep; 66(8):44B-55B. PubMed ID: 2206036
[TBL] [Abstract][Full Text] [Related]
24. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.
Mortensen SA; Leth A; Agner E; Rohde M
Mol Aspects Med; 1997; 18 Suppl():S137-44. PubMed ID: 9266515
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
26. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
27. Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
Jacob BG; Richter WO; Schwandt P
J Cardiovasc Pharmacol; 1993 Sep; 22(3):396-400. PubMed ID: 7504129
[TBL] [Abstract][Full Text] [Related]
28. Double-masked comparison of the quality of life of hypercholesterolemic men treated with simvastatin or pravastatin. International Quality of Life Multicenter Group.
Seed M; Weir MR
Clin Ther; 1999 Oct; 21(10):1758-70. PubMed ID: 10566571
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia.
Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Ogawa N; Goto Y
Atherosclerosis; 2002 Jun; 162(2):373-9. PubMed ID: 11996957
[TBL] [Abstract][Full Text] [Related]
31. Lovastatin in pravastatin comparative trial: cost-effectiveness.
Farbstein S
Am J Cardiol; 1994 Feb; 73(5):417-8. PubMed ID: 8179675
[No Abstract] [Full Text] [Related]
32. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
[TBL] [Abstract][Full Text] [Related]
33. The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group.
Rubenfire M; Maciejko JJ; Blevins RD; Orringer C; Kobylak L; Rosman H
Arch Intern Med; 1991 Nov; 151(11):2234-40. PubMed ID: 1953228
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia.
Chan P; Tomlinson B; Lee CB; Lee YS
J Clin Pharmacol; 1996 May; 36(5):422-7. PubMed ID: 8739021
[TBL] [Abstract][Full Text] [Related]
36. Lovastatin versus pravastatin for hypercholesterolemia.
Goldstein MR
Am J Cardiol; 1994 Feb; 73(5):416; author reply 417-8. PubMed ID: 8109563
[No Abstract] [Full Text] [Related]
37. A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients.
Contermans J; Smit JW; Bär PR; Erkelens DW
Br J Clin Pharmacol; 1995 Feb; 39(2):135-41. PubMed ID: 7742151
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of pravastatin and lovastatin on sleep disturbance in hypercholesterolemic subjects.
Ehrenberg BL; Lamon-Fava S; Corbett KE; McNamara JR; Dallal GE; Schaefer EJ
Sleep; 1999 Feb; 22(1):117-21. PubMed ID: 9989373
[TBL] [Abstract][Full Text] [Related]
40. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
